Pamt [PTSI] vs XPO [XPO] Detailed Stock Comparison

Pamt

XPO
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Pamt wins in 8 metrics, XPO wins in 10 metrics, with 0 ties. XPO appears stronger overall.
View Metrics Details
Vital Metrics Comparison
Metric | Pamt | XPO | Better |
---|---|---|---|
P/E Ratio (TTM) | 312.40 | 44.46 | XPO |
Price-to-Book Ratio | 0.80 | 8.50 | Pamt |
Debt-to-Equity Ratio | 0.93 | 238.63 | Pamt |
PEG Ratio | -5.18 | -1.47 | Pamt |
EV/EBITDA | 4.07 | 15.72 | Pamt |
Profit Margin (TTM) | 10.34% | 4.31% | Pamt |
Operating Margin (TTM) | 4.66% | 9.95% | XPO |
EBITDA Margin (TTM) | 4.66% | 9.95% | XPO |
Return on Equity | 5.86% | 21.04% | XPO |
Return on Assets (TTM) | 2.42% | 5.63% | XPO |
Free Cash Flow (TTM) | $80.52M | $19.00M | Pamt |
1-Year Return | -32.32% | 20.93% | XPO |
Price-to-Sales Ratio (TTM) | 0.31 | 1.89 | Pamt |
Enterprise Value | $411.90M | $19.16B | XPO |
EV/Revenue Ratio | 0.51 | 2.39 | Pamt |
Gross Profit Margin (TTM) | 6.57% | 12.88% | XPO |
Revenue per Share (TTM) | $37 | $68 | XPO |
Earnings per Share (Diluted) | $0.83 | $2.89 | XPO |
Beta (Stock Volatility) | N/A | 1.76 | N/A |
Pamt vs XPO Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
Stock | 1D | 1W | 1M | 3M | 6M | YTD |
---|---|---|---|---|---|---|
Pamt | 0.62% | -7.57% | -2.32% | -20.18% | 2.16% | -29.20% |
XPO | 3.85% | 1.94% | 2.11% | -2.75% | 33.84% | -3.02% |
Long-term Returns
Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
---|---|---|---|---|---|---|
Pamt | -32.32% | -65.27% | 8.10% | 23.50% | 268.51% | 183.04% |
XPO | 20.93% | 343.56% | 289.98% | 1,141.55% | 4,005.43% | 14,020.88% |
News Based Sentiment: Pamt vs XPO
Pamt
News based Sentiment: NEGATIVE
Pamt Corp experienced a challenging month with a significant quarterly loss and a substantial year-to-date stock decline. While some analyst optimism exists, the overall picture suggests ongoing concerns about the company's financial performance and future prospects, making it a noteworthy but concerning month for investors.
XPO
News based Sentiment: POSITIVE
October proved to be a positive month for XPO, driven by a strong Q2 earnings beat, multiple analyst upgrades, and a positive outlook from Moody's. While a decrease in LTL tonnage is a concern, the overall narrative is one of improving financial health and strategic execution, making it a favorable month for investors.
Performance & Financial Health Analysis: Pamt vs XPO
Metric | PTSI | XPO |
---|---|---|
Market Information | ||
Market Cap | $249.94M | $15.18B |
Market Cap Category | Micro cap | Large cap |
10 Day Avg. Volume | 8,626 | 1,121,360 |
90 Day Avg. Volume | 9,045 | 1,146,047 |
Last Close | $11.42 | $133.45 |
52 Week Range | $10.71 - $23.70 | $85.06 - $161.00 |
% from 52W High | -51.81% | -17.11% |
All-Time High | $40.88 (Nov 15, 2021) | $161.00 (Dec 16, 2024) |
% from All-Time High | -72.06% | -17.11% |
Growth Metrics | ||
Quarterly Revenue Growth | 0.00% | 0.06% |
Quarterly Earnings Growth | -0.09% | -0.29% |
Financial Health | ||
Profit Margin (TTM) | 0.10% | 0.04% |
Operating Margin (TTM) | 0.05% | 0.10% |
Return on Equity (TTM) | 0.06% | 0.21% |
Debt to Equity (MRQ) | 0.93 | 238.63 |
Cash & Liquidity | ||
Book Value per Share (MRQ) | $14.19 | $15.13 |
Cash per Share (MRQ) | N/A | $1.91 |
Operating Cash Flow (TTM) | $128.05M | $842.00M |
Levered Free Cash Flow (TTM) | $1.02B | $112.13M |
Dividends | ||
Last 12-Month Dividend Yield | N/A | N/A |
Last 12-Month Dividend | $0.00 | $0.00 |
Valuation & Enterprise Metrics Analysis: Pamt vs XPO
Metric | PTSI | XPO |
---|---|---|
Price Ratios | ||
P/E Ratio (TTM) | 312.40 | 44.46 |
Forward P/E | 22.41 | 29.14 |
PEG Ratio | -5.18 | -1.47 |
Price to Sales (TTM) | 0.31 | 1.89 |
Price to Book (MRQ) | 0.80 | 8.50 |
Market Capitalization | ||
Market Capitalization | $249.94M | $15.18B |
Enterprise Value | $411.90M | $19.16B |
Enterprise Value Metrics | ||
Enterprise to Revenue | 0.51 | 2.39 |
Enterprise to EBITDA | 4.07 | 15.72 |
Risk & Other Metrics | ||
Beta | N/A | 1.76 |
Book Value per Share (MRQ) | $14.19 | $15.13 |
Financial Statements Comparison: Pamt vs XPO
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
Metric (MRQ) | PTSI | XPO |
---|---|---|
Revenue/Sales | $182.58M | $2.08B |
Cost of Goods Sold | $170.59M | $1.81B |
Gross Profit | $11.99M | $268.00M |
Research & Development | N/A | N/A |
Operating Income (EBIT) | $2.10M | $207.00M |
EBITDA | $23.59M | $338.00M |
Pre-Tax Income | $3.12M | $143.00M |
Income Tax | $705,000 | $37.00M |
Net Income (Profit) | $2.41M | $106.00M |
Balance Sheet & Liquidity Metrics (MRQ)
Metric (MRQ) | PTSI | XPO |
---|---|---|
Cash & Equivalents | $48.08M | $212.00M |
Total Current Assets | $208.07M | $1.58B |
Total Current Liabilities | $115.84M | $1.55B |
Long-Term Debt | $227.54M | $3.92B |
Total Shareholders Equity | $308.91M | $1.64B |
Retained Earnings | $281.69M | $641.00M |
Property, Plant & Equipment | $726.20M | $6.36B |
Cash Flow Statement Comparison (MRQ)
Metric (MRQ) | PTSI | XPO |
---|---|---|
Operating Cash Flow | $18.47M | $109.00M |
Capital Expenditures | $-38.99M | $-192.00M |
Free Cash Flow | $-33.61M | $-57.00M |
Debt Repayment | $-197.29M | $-18.00M |
Common Stock Repurchase | $0 | N/A |
Short Interest & Institutional Ownership Analysis
Metric | PTSI | XPO |
---|---|---|
Shares Short | N/A | 9.55M |
Short Ratio | N/A | 8.35 |
Short % of Float | N/A | 0.11% |
Average Daily Volume (10 Day) | 8,626 | 1,121,360 |
Average Daily Volume (90 Day) | 9,045 | 1,146,047 |
Shares Outstanding | 22.02M | 117.17M |
Float Shares | N/A | 104.10M |
% Held by Insiders | N/A | 0.02% |
% Held by Institutions | N/A | 1.08% |
Dividend Analysis & Yield Comparison: Pamt vs XPO
Metric | PTSI | XPO |
---|---|---|
Last 12-Month Dividend | $0.00 | $0.00 |
Last 12-Month Dividend Yield | N/A | N/A |
3-Year Avg Annual Dividend | $0.00 | $0.00 |
3-Year Avg Dividend Yield | N/A | N/A |
3-Year Total Dividends | $0.00 | $0.00 |
Ex-Dividend Date | N/A | N/A |